Page last updated: 2024-08-18
framycetin and snx 230
framycetin has been researched along with snx 230 in 2 studies
Research
Studies (2)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Glossmann, H; Grabner, M; Grabner-Weiss, C; Hering, S; Pichler, M; Reimer, D; Striessnig, J; Wang, Z | 1 |
Dobrev, D; Ravens, U | 1 |
Other Studies
2 other study(ies) available for framycetin and snx 230
Article | Year |
---|---|
Block of P/Q-type calcium channels by therapeutic concentrations of aminoglycoside antibiotics.
Topics: Animals; Anti-Bacterial Agents; Barium; Calcium Channel Blockers; Calcium Channels; Female; Guinea Pigs; Kanamycin; Mollusk Venoms; Neomycin; omega-Conotoxins; Peptides; Streptomycin; Tobramycin; Xenopus | 1996 |
Therapeutically relevant concentrations of neomycin selectively inhibit P-type Ca2+ channels in rat striatum.
Topics: Animals; Calcium; Calcium Channel Blockers; Calcium Channels, N-Type; Calcium Channels, P-Type; Calcium Channels, Q-Type; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; In Vitro Techniques; Male; Neomycin; omega-Agatoxin IVA; omega-Conotoxin GVIA; omega-Conotoxins; Potassium; Rats; Rats, Wistar; Tritium; Veratridine | 2003 |